The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis
Fazekas, F., Barkhof, F., Filippi, M., Grossman, R. I., Li, D. K. B., McDonald, W. I., McFarland, H. F., Paty, D. W., Simon, J. H., Wolinsky, J. S., et al. (1999) · Neurology · doi:10.1212/wnl.53.3.448 · Cited by 287
Self-citation
Cited by
Clinical uses of intravenous immunoglobulin
Jolles, S., Sewell, W. A. C., & Misbah, S. A. (2005) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2005.02834.x · Cited by 374
Treatment of multiple sclerosis — success from bench to bedside
Tintore, M., Vidal-Jordana, A., & Sastre-Garriga, J. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-018-0082-z · Cited by 343
Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes
De Stefano, N., Giorgio, A., Battaglini, M., Rovaris, M., Sormani, M. P., Barkhof, F., Korteweg, T., Enzinger, C., Fazekas, F., Calabrese, M., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e24136 · Cited by 321
Self-citationSecondary progressive multiple sclerosis: current knowledge and future challenges
Rovaris, M., Confavreux, C., Furlan, R., Kappos, L., Comi, G., & Filippi, M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70410-0 · Cited by 303
Tourbah, A., Lebrun-Frenay, C., Edan, G., Clanet, M., Papeix, C., Vukusic, S., De Sèze, J., Debouverie, M., Gout, O., Clavelou, P., et al. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516667568 · Cited by 302
Metadata
- Authors
- Hommes, O. R., Sørensen, P. S., Fazekas, F., Enriquez, M. M., Koelmel, H. W., Fernandez, O., Pozzilli, C., & O'Connor, P.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2004-09
- Volume
- 364
- Issue
- 9440
- Pages
- 1149-1156
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2120793461
- Cited by
- 182
- References
- 2
- FWCI
- 9.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(04)17101-8
- The paper
- Hommes, O. R., Sørensen, P. S., Fazekas, F., Enriquez, M. M., Koelmel, H. W., Fernandez, O., Pozzilli, C., & O'Connor, P. (2004). Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(04)17101-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.